Clinical Radiology
Volume 65, Issue 6 , Pages 453-459 , June 2010

Significance of internal mammary lymph nodes in patients after mastectomy with tissue-expander reconstruction: a case–control study

  • R. Kaewlai

      Affiliations

    • Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationGuarantor and correspondent: R. Kaewlai, Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, FND-210, Boston, MA 02114, USA. Tel.: +1 617 724 5246; fax: +1 617 726 3077.
    • ,
  • S.R. Digumarthy

      Affiliations

    • Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • ,
  • B.L. Smith

      Affiliations

    • Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • ,
  • A.D. Corben

      Affiliations

    • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • Current address: Department of Pathology, Memorial Sloan Kettering Cancer Center Breast and Imaging Center 300 East 66th Street, New York, NY 10065, USA.
    • ,
  • W.G. Austen Jr.

      Affiliations

    • Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • ,
  • J.-A.O. Shepard

      Affiliations

    • Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • ,
  • A. Sharma

      Affiliations

    • Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Received 30 September 2009 ,Revised 10 January 2010 ,Accepted 14 January 2010.

References 

  1. Rubin P, Bunyagidj S, Poulter C. Internal mammary lymph node metastases in breast cancer: detection and management. Am J Roentgenol Radium Ther Nucl Med. 1971;111:588–598
  2. Sharma A, Fidias P, Hayman LA, et al. Patterns of lymphadenopathy in thoracic malignancies. RadioGraphics. 2004;24:419–434
  3. Chen RC, Lin NU, Golshan M, et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management — a systematic review. J Clin Oncol. 2008;26:4981–4989
  4. Purushotham AD, Cariati M. Internal mammary nodes and breast cancer. Br J Surg. 2005;92:131–132
  5. Petrovsky A, Trigolosov A, Vishnevskaya Y, Polyakov B, Tjulandin S, Nechushkin M. Breast cancer staging and treatment planning according to internal mammary lymph node status. J Clin Oncol 2005 ASCO annual meeting proceedings. Vol 23, No 16S (June 1 Supplement), 2005; 718.
  6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  7. Byrd DR, Dunnwald LK, Mankoff DA, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol. 2001;8:234–240
  8. Cranenbroek S, van der Sangen MJ, Kuijt GP, et al. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat. 2005;89:271–275
  9. Kao CC, Rand RP, Holt CA, et al. Internal mammary silicone lymphadenopathy mimicking recurrent breast cancer. Plast Reconstr Surg. 1997;99:225–229
  10. Henriksen TF, Fryzek JP, Holmich LR, et al. Reconstructive breast implantation after mastectomy for breast cancer: clinical outcomes in a nationwide prospective cohort study. Arch Surg. 2005;140:1152–1159discussion 1160–1151
  11. Meyer JE, Munzenrider JE. Computed tomographic demonstration of internal mammary lymph-node metastasis in patients with locally recurrent breast carcinoma. Radiology. 1981;139:661–663
  12. Foldi E, Foldi M, Clodius L. The lymphedema chaos: a lancet. Ann Plast Surg. 1989;22:505–515
  13. Katzin WE, Centeno JA, Feng LJ, et al. Pathology of lymph nodes from patients with breast implants: a histologic and spectroscopic evaluation. Am J Surg Pathol. 2005;29:506–511
  14. Eubank WB, Mankoff DA, Takasugi J, et al. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol. 2001;19:3516–3523
  15. Harisinghani MG, Weissleder R. Sensitive, noninvasive detection of lymph node metastases. PLoS Med. 2004;1:e66
  16. Harisinghani MG, Dixon WT, Saksena MA, et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. RadioGraphics. 2004;24:867–878
  17. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006;7:52–60
  18. Stets C, Brandt S, Wallis F, et al. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging. 2002;16:60–68
  19. Pandharipande PV, Harisinghani MG, Ozanne EM, et al. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008;191:1308–1319
  20. Michel SC, Keller TM, Frohlich JM, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology. 2002;225:527–536

PII: S0009-9260(10)00069-3

doi: 10.1016/j.crad.2010.01.015

Clinical Radiology
Volume 65, Issue 6 , Pages 453-459 , June 2010

Article Tools

* Image Usage & Resolution